Prolactin (PRL) secretion is regulated by hypothalamic dopaminergic systems such as the tuberoinfundibular, tuberohypophyseal and periventricular hypophyseal dopaminergic neurons. Dopamine from these neurons diffuses into capillaries of the pituitary portal blood vessels and is transported to the anterior pituitary, where it acts on dopamine receptor D2 (DRD2) on lactotrophs to inhibit PRL secretion. 1 DRD2 has been extensively investigated in relation to its pathological association with neuropsychiatric disorders such as drug addiction, 2 schizophrenia 3 and Parkinson's disease. 4 The DRD2 single-nucleotide polymorphisms (SNPs) -141C ins/del, Ser311Cys and Taq1 A have been reported to be associated with these neuropsychiatric disorders and antipsychotic response; however, these associations have not been consistently replicated. Furthermore, it was recently reported that Taq1 A is located not within DRD2, but within the ankyrin repeat and kinase domain containing 1 gene, less than 10 kb downstream of DRD2. Therefore, detecting the significant functional DRD2 polymorphisms may be important in understanding the pathogenesis of these neuropsychiatric disorders.
In this study, we hypothesized that the basal PRL level of healthy subjects would accurately reflect DRD2 function. To identify candidate functional DRD2 polymorphisms, we investigated the association of the basal PRL levels with DRD2 'tagging' SNPs that covered the DRD2 gene, and also with Taq1 A, Ser311Cys and -141C ins/del. This study was approved by the Ethics Committee on Genetics of the Niigata University School of Medicine. All subjects received an explanation of the objectives of the study, and only those who gave written consent to participate were enrolled. The subjects comprised 140 healthy Japanese (78 men and 62 women; mean age 35.5 (s.d. 9.7) years), who were mainly recruited from the staff of our hospitals. The subjects did not receive any medication for at least 4 weeks before blood sampling for measurement of PRL levels. The subjects did not have any physical illness as confirmed by medical history and laboratory data, including hematology, serology and urine analysis. Fasting blood samples were collected at 0900 hours for measurements of PRL. PRL concentrations were measured by enzyme immunoassay (SRL, Tokyo, Japan).
Tagging SNPs for the DRD2 genomic region (chr11: 112785528.112851091) were selected from the HapMap database, as described previously.
5 DRD2 polymorphisms were genotyped using the TaqMan  5 0 -exonuclease assay, as described previously. 6 Recently, Rogaeva et al. 7 reported that rs2734836 is located adjacent to the dual repressor element that is repressed by coiled-coil and C2 domain-containing 1A, which is a transcriptional repressor of DRD2. Therefore, we also genotyped rs2734836.
We performed multiple regression analysis with PRL concentration as the dependent variable and genotype, age and body mass index (BMI) as independent variables, using SPSS II software for Windows (SPSS Japan, Tokyo, Japan). As it is well known that there is a sex difference in the PRL concentration, we performed the multiple regression analysis by dividing subject group into men and women. The level of statistical significance was set at P < 0.05.
None of the SNP genotype distributions deviated significantly from Hardy-Weinberg equilibrium (P > 0.05) in our subjects (n = 140). In the male group, the mean PRL concentration, age and BMI were 11. 5 , respectively. In our subjects (n = 140), there was strong linkage disequilibrium between SNP 7 (rs7131056) and SNP 8 (rs4648317) (D 0 = 1.0, r 2 = 0.58). The PRL concentration was negatively correlated with age in the female group and weakly correlated with BMI in the male group (Table 1) .
In the present study, we found significant associations between the DRD2 polymorphisms rs7131056 and rs4648317 (both located in intron 1) and serum PRL levels in healthy and female Japanese subjects. Consequently, these SNPs can now be considered candidate functional DRD2 polymorphisms. Furthermore, these SNPs have been reported to be associated with several conditions such as smoking behavior, 8 behavioral inhibition/impulsivity 9 and migraine. 10 We hope that our preliminary data would be compensated by further studies dealing with a large number of subjects and different populations, and that the studies would take into account the sex differences in the regulation of PRL levels by dopaminergic systems and the confounding effect of age on PRL levels. Detecting significant functional DRD2 polymorphisms will contribute to an understanding of the pathology of dopamine-related disorders. 
